TipRanks
Advertisement
Advertisement

RDY Stock Latest News

Dr. Reddy’s Laboratories Files Q2 FY 2027 Unaudited Results with SEC and Indian Exchanges
Company AnnouncementsDr. Reddy’s Laboratories Files Q2 FY 2027 Unaudited Results with SEC and Indian Exchanges
9m ago
6K
RDY
Dr. Reddy’s Elevates Aurigene CEO Akhil Ravi to Head API and Services
PremiumCompany Announcements
Dr. Reddy’s Elevates Aurigene CEO Akhil Ravi to Head API and Services
19m ago
6K
RDY
Dr. Reddy’s Releases Q2 FY27 Unaudited Results Presentation
PremiumCompany Announcements
Dr. Reddy’s Releases Q2 FY27 Unaudited Results Presentation
38m ago
6K
RDY
Dr. Reddy’s Interim Q2 FY 2026 Results Receive Clean Auditor Review
PremiumCompany Announcements
Dr. Reddy’s Interim Q2 FY 2026 Results Receive Clean Auditor Review
2h ago
6K
RDY
RDY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
RDY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2d ago
RDY
Dr. Reddy’s Receives USFDA Form 483 After Pre-Approval Inspection at Visakhapatnam Plant
PremiumCompany AnnouncementsDr. Reddy’s Receives USFDA Form 483 After Pre-Approval Inspection at Visakhapatnam Plant
9d ago
6K
RDY
Dr. Reddy’s upgraded to Outperform from Neutral at BNP Paribas
Premium
The Fly
Dr. Reddy’s upgraded to Outperform from Neutral at BNP Paribas
11d ago
RDY
Dr. Reddy’s Receives Two-Observation USFDA Form 483 After PAI at FTO-11
Premium
Company Announcements
Dr. Reddy’s Receives Two-Observation USFDA Form 483 After PAI at FTO-11
15d ago
6K
RDY
Dr. Reddy’s Sets October 23 Date for Q2 FY27 Results and Global Earnings Call
PremiumCompany Announcements
Dr. Reddy’s Sets October 23 Date for Q2 FY27 Results and Global Earnings Call
16d ago
6K
RDY
Dr. Reddy’s U.S. Subsidiary Hit with Modest IRS Penalty, Assessed as Non‑Material
PremiumCompany Announcements
Dr. Reddy’s U.S. Subsidiary Hit with Modest IRS Penalty, Assessed as Non‑Material
18d ago
6K
RDY
Dr. Reddy’s double-upgraded to Buy from Sell at Citi
PremiumThe Fly
Dr. Reddy’s double-upgraded to Buy from Sell at Citi
25d ago
RDY
Dr. Reddy’s Schedules October 23 Board Meet, Closes Trading Window Ahead of Q2 Results
PremiumCompany Announcements
Dr. Reddy’s Schedules October 23 Board Meet, Closes Trading Window Ahead of Q2 Results
1M ago
6K
RDY
Dr. Reddy’s Schedules Nomura-Led Investor Meet in Hyderabad
PremiumCompany AnnouncementsDr. Reddy’s Schedules Nomura-Led Investor Meet in Hyderabad
1M ago
6K
RDY
Dr. Reddy’s, Takeda Seal Exclusive Deal to Launch First Approved Dengue Vaccine in India’s Private Market
Premium
Company Announcements
Dr. Reddy’s, Takeda Seal Exclusive Deal to Launch First Approved Dengue Vaccine in India’s Private Market
1M ago
6K
RDY
Dr. Reddy’s Reports FDA Records Assessment at Mexican API Plant Concluding with Two Observations
Premium
Company Announcements
Dr. Reddy’s Reports FDA Records Assessment at Mexican API Plant Concluding with Two Observations
1M ago
6K
RDY
Immutep provides update on development strategy for eftilagimod alfa
PremiumThe Fly
Immutep provides update on development strategy for eftilagimod alfa
1M ago
RDY
IMMP
Dr. Reddy’s Issues New ESOP Shares After ADR Option Exercise
PremiumCompany Announcements
Dr. Reddy’s Issues New ESOP Shares After ADR Option Exercise
1M ago
6K
RDY
Dr. Reddy’s Schedules September Analyst and Investor Meetings
PremiumCompany Announcements
Dr. Reddy’s Schedules September Analyst and Investor Meetings
1M ago
6K
RDY
Dr. Reddy’s Laboratories Allots New Shares Under Employee Stock Option Scheme
PremiumCompany Announcements
Dr. Reddy’s Laboratories Allots New Shares Under Employee Stock Option Scheme
2M ago
6K
RDY
RDY Backs Keytruda Biosimilar Trial in Melanoma: What Investors Should Watch
PremiumCompany AnnouncementsRDY Backs Keytruda Biosimilar Trial in Melanoma: What Investors Should Watch
2M ago
RDY
Dr. Reddy’s Receives USFDA Form 483 for Bachupally Plant After August Inspection
Premium
Company Announcements
Dr. Reddy’s Receives USFDA Form 483 for Bachupally Plant After August Inspection
2M ago
6K
RDY
Dr. Reddy’s Receives VAI Classification as USFDA Closes Inspection of U.K. API Plant
Premium
Company Announcements
Dr. Reddy’s Receives VAI Classification as USFDA Closes Inspection of U.K. API Plant
2M ago
6K
RDY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >